No Detail Found!

Evaluating the comparative efficacy of multimodal treatment strategies for hyperkalemia management in a Tertiary Care Hospital setting: A prospective cohort study

Author(s)
Bushra Muzamil Patel Department of Pharmacology, Faculty of Pharmacy, Hamdard University,Karachi,Pakistan
Humera Ishaq Department of Pharmacology, Shaheed Mohtarma Benazir Bhutto Medical College,Karachi,Pakistan
Muzamil Patel Department of Pharmacology, Faculty of Pharmacy, Hamdard University,Karachi,Pakistan
Adnan Iqbal Department of Pharmacology, Faculty of Pharmacy, University of Karachi,Karachi,Pakistan
Shoaib Alam Department of Pharmacy, Sindh Government Hospital-Korangi,Karachi,Pakistan
Khalid Orayj Department of Clinical Pharmacy, College of Pharmacy, King Khalid University,Abha,Saudi Arabia
Asif Ansari Shaik Mohammad Department of Clinical Pharmacy, College of Pharmacy, King Khalid University,Abha,Saudi Arabia
Azfar Athar Ishaqui Department of Clinical Pharmacy, College of Pharmacy, King Khalid University,Abha,Saudi Arabia
Abstract
Hyperkalemia poses significant risks to patients due to its potential to cause life-threatening cardiac and neuromuscular complications. This study aimed to evaluate the effectiveness of different treatment protocols for hyperkalemia in hospitalized patients. This prospective observational study, conducted at Sindh Government Hospital Korangi, Karachi, included adult patients (>18 years) with potassium levels =5.5 mEq/L. The study evaluated the effectiveness of different treatments in normalizing potassium levels, with treatment choices made at the discretion of the treating physicians. Among the 341 patients, treatment effectiveness varied by hyperkalemia severity. For mild hyperkalemia, D50W with insulin and sodium bicarbonate achieved normokalemia in 83.3% of cases, compared to 55% with Sodium-Polysorbate alone. In moderate hyperkalemia (189 patients), the combination of D50W, insulin, sodium bicarbonate, calcium gluconate and Sodium-Polysorbate reduced potassium levels from 6.52 to 6.01 mmol/L (p<0.001), with 27.2% achieving normokalemia. In severe hyperkalemia (104 patients), this regimen led to significant reductions (0.88-1.18 mmol/L, p<0.001), with 17.6% reaching normokalemia. Multi-drug approaches are advocated for effective hyperkalemia management, particularly for moderate to severe cases. Future research should focus on refining treatment protocols and improving adherence to guidelines to ensure consistent management outcomes.
Publication Details
Page(s) 55-60
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 38, Issue: 1, Year: 2025

Request the full text from PASTIC

Keywords
Hypokalemia, Hyperkalemia, American Heart Association, European Resuscitation Council Guidelines
References
Alam S,Ishaqui AA,Khan MA,Iqbal A,Jawed SH,Khalid F,Uzairullah MM,Talha M,Ashfaq U,Zehra N U .2019 .Evaluation of single dose sodium polystyrene sulfonate for management of hyperkalemia and its effect on other serum electrolytes. Pak. Armed Forces Med, 69(1) : 37-42.
Cheung AK,Chang TI,Cushman WC,Furth SL,Hou FF,Ix JH,Knoll GA,Muntner P,Pecoits-Filho R,Sarnak MJJKI .2021 .KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int, 99(3) : S1-S87.
Cowan AC,Gharib EG .2017 .Advances in the management of hyperkalemia in chronic kidney disease. Curr. Opin. Nephrol, 26(3) : 235-239.
Evans KJ,Greenberg A .2005 .Hyperkalemia: A review. J. Intensive Care Med, 20(5) : 272-290.
Fordjour KN,Walton T,Doran JJ .2014 .Management of hyperkalemia in hospitalized patients. Amer. J. Med. Sci., 347(2) : 93-100.
Gennari FJ .2002 .Disorders of potassium homeostasis: Hypokalemia and hyperkalemia. Crit. Care Clin., 18(2) : 273-288.
Halperin ML,Kamel KSJTL .1998 .. , 352(9122) : 135-140.
Hoskote SS,Joshi SR,Ghosh AK .2008 .Disorders of potassium homeostasis: Pathophysiology and management. JAPI., 56 : 685-725.
Kim HJ,Han SWJN .2002 .Therapeutic approach to hyperkalemia. , 92(Suppl 1) : 33-40.
Kovesdy CPJT Ajom .2015 .Management of hyperkalemia: An update for the internist. Am. J. Med, 128(12) : 1281-1287.
Mount DB .2024 .-manifestations-and-treatment-of-hypokalemiain-adults;. Last accessed: 1th July, : .
Palmer BF,Carrero JJ,Clegg DJ,Colbert GB,Emmett M,Fishbane S,Hain DJ,Lerma E,Onuigbo M,Rastogi A .2021 .Clinical management of hyperkalemia. Mayo Clinic Proceedings. Elsevier, 96(3) : 744-762.
Rafique Z,Peacock F,Armstead T,Bischof JJ,Hudson J,Weir MR,Neuenschwander JJJotACoEPO MR .2021 .Hyperkalemia management in the emergency department: An expert panel consensus. J. Am. Coll. Emerg. Physicians Open, 2(5) : e12572.
Simon LV,Farrell MW .2018 .. , : .
Sterns RH,Grieff M,Bernstein PLJKi M .2016 .Treatment of hyperkalemia: something old, something new. Kidney Int, 89(3) : 546-554.
Viera AJ,Wouk N AJ .2015 .Potassium disorders: Hypokalemia and hyperkalemia. Am. Fam. Physician, 92(6) : 487-95.
Weisberg LSJCcm .2008 .Management of severe hyperkalemia. Crit. Care Med, 36(12) : 3246-3251.
0

Citations

0

Downloads

117

Views